Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19
Tocilizumab has been proposed as a means of opposing hyperinflammatory responses in intensive care patients with COVID-19. Here, we briefly discuss the potentially multiple, synergistic mechanisms whereby tocilizumab might exert therapeutic activity, mostly focusing on the production of tryptophan-d...
Saved in:
Main Authors: | Maria Laura Belladonna (Author), Ciriana Orabona (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tocilizumab and COVID-19: Timing of Administration and Efficacy
by: Emna Abidi, et al.
Published: (2022) -
Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
by: Rania M. Sarhan, et al.
Published: (2022) -
The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism
by: Dietmar Fuchs, et al.
Published: (2010) -
<i>Crocus sativus</i> L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell Model
by: Ciriana Orabona, et al.
Published: (2022) -
Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study
by: Ayman M. Al-Qaaneh, et al.
Published: (2022)